Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.
To stop the spread of infectious diseases, the U.S. should invest in community health programs around the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback